As a novel candidate for antitumour VM and anti-covariance treatment, miR-27b might bind to the 3’-untranslated region (3’UTR) of VE-cadherin mRNA to reduce the production of VE-cadherin in ovarian cancer cells (88). Here, CDH5 is linked to ovarian carcinoma.